|
|
Volumn 32, Issue 36, 2014, Pages 4027-4028
|
|
Payment for cancer care: Time for a new prescription
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
PACLITAXEL;
PRESCRIPTION DRUG;
ACT;
ANDROGEN DEPRIVATION THERAPY;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
COLORECTAL CANCER;
DOCTOR PATIENT RELATION;
EDITORIAL;
EVIDENCE BASED PRACTICE;
GENE MUTATION;
GOLD STANDARD;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE POLICY;
HEALTH SERVICE;
HUMAN;
INTERPERSONAL COMMUNICATION;
MEDICAL DECISION MAKING;
MEDICAL FEE;
MEDICARE;
ONCOGENE RAS;
OUTCOMES RESEARCH;
PATIENT CARE;
PATIENT COUNSELING;
PATIENT EDUCATION;
PATIENT PREFERENCE;
PROSTATE CANCER;
REIMBURSEMENT;
COLORECTAL NEOPLASMS;
DRUG UTILIZATION;
FEMALE;
LEGISLATION AND JURISPRUDENCE;
LUNG NEOPLASMS;
MALE;
MEDICAID;
ONCOLOGY;
ANTINEOPLASTIC AGENTS;
COLORECTAL NEOPLASMS;
DRUG UTILIZATION;
FEE-FOR-SERVICE PLANS;
FEMALE;
HEALTH CARE REFORM;
HEALTH POLICY;
HUMANS;
LUNG NEOPLASMS;
MALE;
MEDICAID;
MEDICAL ONCOLOGY;
MEDICARE PART D;
PRESCRIPTION DRUGS;
|
|
EID: 84919754167
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2014.57.9573 Document Type: Editorial |
|
Times cited : (7)
|
|
References (12)
|
